AU2002241548A1 - A bilayer structure which encapsulates multiple containment units and uses thereof - Google Patents
A bilayer structure which encapsulates multiple containment units and uses thereofInfo
- Publication number
- AU2002241548A1 AU2002241548A1 AU2002241548A AU4154802A AU2002241548A1 AU 2002241548 A1 AU2002241548 A1 AU 2002241548A1 AU 2002241548 A AU2002241548 A AU 2002241548A AU 4154802 A AU4154802 A AU 4154802A AU 2002241548 A1 AU2002241548 A1 AU 2002241548A1
- Authority
- AU
- Australia
- Prior art keywords
- bilayer structure
- containment units
- multiple containment
- encapsulates multiple
- encapsulates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24570100P | 2000-11-02 | 2000-11-02 | |
US60/245,701 | 2000-11-02 | ||
US09/842,240 US6565889B2 (en) | 1996-12-02 | 2001-04-24 | Bilayer structure which encapsulates multiple containment units and uses thereof |
US09/842,240 | 2001-04-24 | ||
PCT/US2001/045247 WO2002045769A2 (en) | 2000-11-02 | 2001-10-31 | A bilayer structure which encapsulates multiple containment units and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002241548A1 true AU2002241548A1 (en) | 2002-06-18 |
Family
ID=26937391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002241548A Abandoned AU2002241548A1 (en) | 2000-11-02 | 2001-10-31 | A bilayer structure which encapsulates multiple containment units and uses thereof |
Country Status (3)
Country | Link |
---|---|
US (1) | US6565889B2 (en) |
AU (1) | AU2002241548A1 (en) |
WO (1) | WO2002045769A2 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL158819A0 (en) * | 2001-05-31 | 2004-05-12 | Skyepharma Inc | Encapsulation of nanosuspensions in liposomes and microspheres |
US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
US20040082521A1 (en) * | 2002-03-29 | 2004-04-29 | Azaya Therapeutics Inc. | Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases |
JP2006508126A (en) * | 2002-11-06 | 2006-03-09 | アザヤ セラピューティクス インコーポレイティッド | Protein-stabilized liposome formulation of pharmaceutical formulation |
JP4394916B2 (en) * | 2003-09-19 | 2010-01-06 | 独立行政法人科学技術振興機構 | Artificial lipid bilayer membrane formation apparatus, artificial lipid bilayer membrane formation method, and use thereof |
WO2005063213A1 (en) * | 2003-12-19 | 2005-07-14 | Biodelivery Sciences International, Inc. | Rigid liposomal cochleate and methods of use and manufacture |
US7485283B2 (en) * | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
US7638092B2 (en) * | 2004-09-17 | 2009-12-29 | Japan Science And Technology Agency | Artificial lipid bilayer membrane lipid substitution method, artificial lipid bilayer membrane obtained by using lipid substitution method, artificial lipid bilayer membrane formation device and ion permeation measuring device |
US20060094053A1 (en) * | 2004-11-04 | 2006-05-04 | Dimitrios Stamou | Self-assembled arrays of lipid-bilayer vesicles |
CA2609402C (en) | 2005-05-23 | 2014-10-21 | Sdg, Inc. | Lipid construct for delivery of insulin to a mammal |
CN101237855A (en) * | 2005-05-23 | 2008-08-06 | Sdg公司 | Lipid construct for delivery of interferon to a mammal |
US20110135725A1 (en) | 2005-05-23 | 2011-06-09 | Sdg, Inc. | Lipid Construct for Delivery of Insulin to a Mammal |
US7824659B2 (en) | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
US20080305157A1 (en) * | 2007-06-08 | 2008-12-11 | University Of Maryland Office Of Technology Commercialization | Encapsulation and separation of charged organic solutes inside catanionic vesicles |
US8962015B2 (en) | 2007-09-28 | 2015-02-24 | Sdg, Inc. | Orally bioavailable lipid-based constructs |
US20110105995A1 (en) * | 2008-01-16 | 2011-05-05 | Zhu Ting F | Uniform-sized, multi-drug carrying, and photosensitive liposomes for advanced drug delivery |
ES2767973T3 (en) | 2008-02-29 | 2020-06-19 | Lantheus Medical Imaging Inc | Contrast agents for applications involving perfusion imaging |
US9687571B2 (en) | 2009-04-15 | 2017-06-27 | Lantheus Medical Imaging, Inc. | Stabilization of radiopharmaceutical compositions using ascorbic acid |
DK2534136T3 (en) | 2010-02-08 | 2017-12-04 | Lantheus Medical Imaging Inc | METHODS OF SYNTHETIZING CONTRAST AGENTS AND INTERMEDIATES THEREOF |
ES2364771B1 (en) * | 2010-03-01 | 2013-01-29 | Consejo Superior De Investigaciones Científicas (Csic) | BICELAS ENCAPSULADAS IN LIPOSOMAS AND ITS APPLICATION IN DILUIDED SYSTEMS. |
AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
KR20150062802A (en) * | 2013-11-29 | 2015-06-08 | 삼성전자주식회사 | Double-layerec liposome comprising a inner liposome comprising hydrophobic active ingredient, and use thereof |
US11077173B2 (en) | 2017-03-13 | 2021-08-03 | Sdg, Inc. | Lipid-based nanoparticles and methods using same |
WO2018169954A1 (en) | 2017-03-13 | 2018-09-20 | Sdg, Inc. | Lipid-based nanoparticles with enhanced stability |
US11389405B2 (en) * | 2017-09-18 | 2022-07-19 | North Carolina State University | Artificial beta cells and methods of use thereof |
WO2019210296A1 (en) * | 2018-04-27 | 2019-10-31 | Karma Biotechnologies | Multi-vesicular liposomes for targeted delivery of drugs and biologics for tissue engineering |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4078052A (en) | 1976-06-30 | 1978-03-07 | The United States Of America As Represented By The Secretary Of Health, Education And Welfare | Large unilamellar vesicles (LUV) and method of preparing same |
US5004566A (en) | 1987-02-06 | 1991-04-02 | Geo-Centers, Inc. | Process for fabrication of lipid microstructures from dry organic solvent |
US5723147A (en) | 1987-02-23 | 1998-03-03 | Depotech Corporation | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
EP0406315B1 (en) | 1988-03-24 | 1992-11-11 | Bukh Meditec A/S | Controlled release composition |
US5492696A (en) | 1989-04-14 | 1996-02-20 | The Government Of The United States Of America As Represented By The Secretary Of The Navy | Controlled release microstructures |
US5643574A (en) | 1993-10-04 | 1997-07-01 | Albany Medical College | Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
US5855911A (en) * | 1995-08-29 | 1999-01-05 | Board Of Regents, The University Of Texas System | Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides |
US5866284A (en) | 1997-05-28 | 1999-02-02 | Hewlett-Packard Company | Print method and apparatus for re-writable medium |
-
2001
- 2001-04-24 US US09/842,240 patent/US6565889B2/en not_active Expired - Fee Related
- 2001-10-31 AU AU2002241548A patent/AU2002241548A1/en not_active Abandoned
- 2001-10-31 WO PCT/US2001/045247 patent/WO2002045769A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002045769A9 (en) | 2003-02-06 |
WO2002045769A3 (en) | 2002-10-10 |
WO2002045769A2 (en) | 2002-06-13 |
US20020061331A1 (en) | 2002-05-23 |
US6565889B2 (en) | 2003-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002241548A1 (en) | A bilayer structure which encapsulates multiple containment units and uses thereof | |
AUPQ339099A0 (en) | A humidifier | |
AU2001240856A1 (en) | Capsules | |
GB0009605D0 (en) | Medicaments | |
GB0031123D0 (en) | Actuator unit | |
AU2001240838A1 (en) | Capsules | |
GB0002312D0 (en) | Medicaments | |
AU1645700A (en) | Oenothein medicaments | |
GB0024362D0 (en) | Medicaments | |
AU6733300A (en) | A learning-assistance system | |
AU143047S (en) | A shelter | |
AU2001282527A1 (en) | Antiparkinsonism drugs | |
AU2001272718A1 (en) | Medicaments | |
AU6896500A (en) | Composite structure incorporating a composite material | |
AU2002221242A1 (en) | A security arrangement | |
AU2002211068A1 (en) | Nuclear transmutational processes | |
AU2001266201A1 (en) | Medicaments | |
AU2001232068A1 (en) | Delivery capsules | |
AU3133800A (en) | Barrier element | |
AU7798900A (en) | Booklet comprising a form | |
GB0128891D0 (en) | Actuator unit | |
AUPQ280199A0 (en) | A barrier element | |
AUPQ261599A0 (en) | A sachet | |
GB0022155D0 (en) | Medicaments | |
GB0022156D0 (en) | Medicaments |